NCT05493098 is a NA clinical trial of dry needling in Episodic Tension-type Headache, sponsored by Iran University of Medical Sciences.

Who is sponsoring NCT05493098?

NCT05493098 is sponsored by Iran University of Medical Sciences.

What drugs are being tested in NCT05493098?

Interventions in NCT05493098: dry needling, sham (placebo) dry needling:.

What condition does NCT05493098 study?

NCT05493098 studies Episodic Tension-type Headache.

Is NCT05493098 still recruiting?

NCT05493098 is currently status unknown. Last updated 16 February 2023.

Last reviewed 2023-02-16 · How we verify

NCT05493098

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Dry Needling in People With Episodic Tension-type Headache

Status unknown NA Last updated 16 February 2023

What this trial tests

NA trial testing dry needling in Episodic Tension-type Headache in 36 participants. Status unknown.

Timeline

30 June 2023

Primary endpoint
30 December 2023

30 December 2023

Quick facts

Lead sponsor	Iran University of Medical Sciences
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	36
Start date	30 June 2023
Primary completion	30 December 2023
Estimated completion	30 December 2023

Drugs / interventions tested

dry needling
sham (placebo) dry needling:

Conditions studied

Episodic Tension-type Headache — all drugs for Episodic Tension-type Headache →

Sponsor

Iran University of Medical Sciences

Who can join

Adults 20 to 50, any sex, with Episodic Tension-type Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Tension-type headache is a widespread disorder, with a lifetime prevalence in the general population ranging between 30% and 78%. Tension-type headache also places a financial burden on society and individuals. Myofascial pain can reduce the range of motion and patterns of muscle activation and play an important role in tension-type headache. Based on the previous studies, dry needling can reduce local and referred pain, increase range of motion and improve patterns of muscle activation in patients with myofascial pain syndrome. The effectiveness of dry needling in patients with tension-type headache is not fully known. Objective: The aim of this study will be to investigate the effectiveness of dry needling on pain, active range of motion, functional disability, and frequency of headache in patients with episodic tension-type headache. Method: This study will be a double-blind randomized controlled trial. Thirty-six patients with episodic tension-type headache will be randomly divided into two groups: the experimental group (dry needling and routine physical therapy) and the control group (sham dry needling and routine physical therapy). The primary outcomes will be pain intensity and active range of motion of the craniocervical region. Functional disability and frequency of headache will be considered secondary outcomes. Outcomes will be assessed before and one week after the intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of dry needling

Trials testing the same drug.

NCT07342790 — Artificial Intelligence Clinical Decision · NA · not yet recruiting
NCT07118397 — Effect of Dry Needling Versus Kinesiology Taping in Patient With Plantar Fasciitis · NA · active not recruiting
NCT07351331 — Intratissue Electrolysis (EPI) is Effective in Deactivating Myofascial Trigger Points (MTrPs). (EPIEMG) · NA · completed
NCT06954688 — The Influence of Dry Needling for Hypertonia and Spasticity Treatment on Neuropathic Pain in Lower Extremity of Spinal C · NA · terminated
NCT06307587 — Vastus Intermedius Dry Needling for Knee Stiffness Resulted From Surgically Managed Femoral Fractures With Open Reductio · NA · not yet recruiting

Other Iran University of Medical Sciences trials

Trials by the same sponsor.

NCT06763627 — The Effectiveness of Gamification vs. Traditional Teaching in Undergraduate Medical Education · NA · completed
NCT05383365 — Deep Neck Flexor Exercises Versus Myofascial Release of Suboccipital Muscles in Chronic Tension-type Headache · NA · not yet recruiting
NCT06193603 — Cupping Therapy in Chronic Nonspecific Low Back Pain · NA · completed
NCT06543667 — Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye · Phase 1 · recruiting
NCT05316142 — Effect of Subconjunctival 5-fluorouracil on the Outcome of Ahmed Valve in Neovascular Glaucoma · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05493098 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Iran University of Medical Sciences
Last refreshed: 16 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05493098.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing